VEGFA and neoplasm: De Bock et al. [194, 200] have documented that tumor cells activate the endothelium metabolic switch through VEGF production leading to enhancement of glycolysis by up-regulation of phosphofructokinase-2/fructose-2,6-bisphosphatase 3 (PFKFB3).